Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Dec;18(12):1010-6.
doi: 10.1136/gut.18.12.1010.

K-lymphocytes (killer-cells) in Crohn's disease and acute virus B-hepatitis

K-lymphocytes (killer-cells) in Crohn's disease and acute virus B-hepatitis

R Eckhardt et al. Gut. 1977 Dec.

Abstract

Total lymphocyte counts, B-, T-, C'3 receptor-bearing lymphocytes, and K-cell activity were studied in peripheral blood in patients with Crohn's disease and inflammatory liver disease. Patients with active untreated Crohn's disease and acute virus B hepatitis exhibited a markedly increased K-cell activity measured in a plaque assay when compared with normal controls (P less than 0.01). Patients with immunosuppressive treated Crohn's disease, HBsAg-positive chronic active hepatitis, and cirrhosis of the liver showed only a slight increase of K-cell activity (P less than 0.01). In the postacute phase of hepatitis (four to 12 weeks from onset) K-cell activity fell to normal levels. The number of B-lymphocytes showed a relative and absolute decrease in all groups of patients. With the exception of patients with acute HBsAg-positive hepatitis and the post-acute phase of hepatitis all the other groups showed statistically decreased absolute numbers for C'3 receptor-bearing lymphocytes. The significant decrease in K-cell activity and the number of T-lymphocytes in Crohn's disease treated with immunosuppressive drugs was interpreted as an effect of azathioprine and prednisone on these lymphocyte subpopulations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1976 Jul;58(1):173-9 - PubMed
    1. Lancet. 1976 Feb 28;1(7957):441-4 - PubMed
    1. J Immunol. 1975 Jul;115(1):249-55 - PubMed
    1. Scand J Immunol. 1975;4(8):859-64 - PubMed
    1. Clin Gastroenterol. 1976 May;5(2):289-302 - PubMed

LinkOut - more resources